| Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells HRC Kim, HM Lin, H Biliran, A Raz Cancer research 59 (16), 4148-4154, 1999 | 421 | 1999 |
| Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells P Laakkonen, ME Åkerman, H Biliran, M Yang, F Ferrer, T Karpanen, ... Proceedings of the National Academy of Sciences 101 (25), 9381-9386, 2004 | 365 | 2004 |
| Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing … H Biliran Jr, Y Wang, S Banerjee, H Xu, H Heng, A Thakur, A Bollig, ... Clinical Cancer Research 11 (16), 6075-6086, 2005 | 218 | 2005 |
| Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis ML Cher, HR Biliran Jr, S Bhagat, Y Meng, M Che, J Lockett, J Abrams, ... Proceedings of the National Academy of Sciences 100 (13), 7847-7852, 2003 | 204 | 2003 |
| Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin H Biliran Jr, S Sheng Cancer research 61 (24), 8676-8682, 2001 | 165 | 2001 |
| The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin R McGowen, H Biliran Jr, R Sager, S Sheng Cancer research 60 (17), 4771-4778, 2000 | 137 | 2000 |
| Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy DJ Liao, A Thakur, J Wu, H Biliran, FH Sarkar Critical Reviews™ in Oncogenesis 13 (2), 2007 | 101 | 2007 |
| Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer A Thakur, KMW Rahman, J Wu, A Bollig, H Biliran, X Lin, H Nassar, ... Molecular cancer research 5 (2), 171-181, 2007 | 100 | 2007 |
| Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells A Thakur, Y Sun, A Bollig, J Wu, H Biliran, S Banerjee, FH Sarkar, DJ Liao Clinical cancer research 14 (14), 4427-4436, 2008 | 95 | 2008 |
| Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system S Yin, J Lockett, Y Meng, H Biliran Jr, GE Blouse, X Li, N Reddy, Z Zhao, ... Cancer research 66 (8), 4173-4181, 2006 | 86 | 2006 |
| TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin X Yao, SK Ireland, T Pham, B Temple, R Chen, MHG Raj, H Biliran Biochemical and biophysical research communications 455 (3-4), 277-284, 2014 | 75 | 2014 |
| C-Myc–induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-κB activity in pancreatic cancer cells H Biliran Jr, S Banerjee, A Thakur, FH Sarkar, A Bollig, F Ahmed, J Wu, ... Clinical cancer research 13 (9), 2811-2821, 2007 | 57 | 2007 |
| Combinatorial regulation of phospholipid biosynthetic gene expression by the UME6, SIN3 and RPD3 genes M Elkhaimi, MR Kaadige, D Kamath, JC Jackson, H Biliran Jr, JM Lopes Nucleic acids research 28 (16), 3160-3167, 2000 | 54 | 2000 |
| The role of X-linked genes in breast cancer A Thakur, H Xu, Y Wang, A Bollig, H Biliran, JD Liao Breast cancer research and treatment 93, 135-143, 2005 | 53 | 2005 |
| Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice Y Wang, A Thakur, Y Sun, J Wu, H Biliran, A Bollig, DJ Liao Cancer research 67 (8), 3698-3707, 2007 | 47 | 2007 |
| Anoikis effector Bit1 negatively regulates Erk activity R Kairouz-Wahbe, H Biliran, X Luo, IW Khor, M Wankell, C Besch-Williford, ... Proceedings of the National Academy of Sciences 105 (5), 1528-1532, 2008 | 43 | 2008 |
| TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells C Brunquell, H Biliran, S Jennings, SK Ireland, R Chen, E Ruoslahti Molecular Cancer Research 10 (11), 1482-1495, 2012 | 42 | 2012 |
| Metastasis of tumor cells is enhanced by downregulation of Bit1 PP Karmali, C Brunquell, H Tram, SK Ireland, E Ruoslahti, H Biliran PLoS One 6 (8), e23840, 2011 | 42 | 2011 |
| The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells X Yao, S Jennings, SK Ireland, T Pham, B Temple, M Davis, R Chen, ... PLoS One 9 (7), e101564, 2014 | 41 | 2014 |
| Bit1 in anoikis resistance and tumor metastasis S Jenning, T Pham, SK Ireland, E Ruoslahti, H Biliran Cancer letters 333 (2), 147-151, 2013 | 40 | 2013 |
